We are live on
!
Find out more
SFO
Stokes Family Office Portfolio holdings
AUM
$969M
1-Year Est. Return
19.6%
This Fund
S&P 500
This Quarter
Est. Return
+7.19%
1 Year Est. Return
+19.6%
3 Year Est. Return
+56.86%
5 Year Est. Return
+67.08%
10 Year Est. Return
–
AUM
$450M
AUM Growth
–
Cap. Flow
+$433M
Cap. Flow
% of AUM
96.25%
Top 10 Holdings %
Top 10 Hldgs %
47.4%
Holding
127
New
127
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
+$62.9M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$22.9M |
| 3 |
Vanguard International High Dividend Yield ETF
VYMI
|
+$20.9M |
| 4 |
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
|
+$19.9M |
| 5 |
Apple
AAPL
|
+$18.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.55% |
| 2 | Communication Services | 6.74% |
| 3 | Healthcare | 5.95% |
| 4 | Consumer Staples | 5.74% |
| 5 | Financials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Baxter International
BAX
$14B
| $422K | 0.09% |
+5,049
| New | +$418K |
|
102
Amgen
AMGN
$219B
| $419K | 0.09% |
+1,736
| New | +$383K |
|
|
DOCU
103
DocuSign
DOCU
$10.9B
| $402K | 0.09% |
+5,424
| New | +$373K |
|
|
EXAS
104
DELISTED
Exact Sciences
EXAS
| $399K | 0.09% |
+4,312
| New | +$379K |
|
105
SLB Ltd
SLB
$76.5B
| $393K | 0.09% |
+9,770
| New | +$349K |
|
106
Netflix
NFLX
$307B
| $387K | 0.09% |
+11,910
| New | +$353K |
|
107
Merck
MRK
$317B
| $377K | 0.08% |
+4,208
| New | +$346K |
|
108
Zimmer Biomet
ZBH
$18.8B
| $365K | 0.08% |
+2,513
| New | +$347K |
|
109
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $343K | 0.08% |
+5,500
| New | +$330K |
|
|
NAV
110
DELISTED
Navistar International
NAV
| $318K | 0.07% |
+11,005
| New | +$338K |
|
111
Alpha Architect US Quantitative Value ETF
QVAL
$597M
| $299K | 0.07% |
+3,314
| New | +$97.9K |
|
112
ConocoPhillips
COP
$142B
| $264K | 0.06% |
+4,052
| New | +$238K |
|
113
CVS Health
CVS
$123B
| $250K | 0.06% |
+3,445
| New | +$242K |
|
114
Enbridge
ENB
$113B
| $243K | 0.05% |
+6,121
| New | +$229K |
|
115
J.M. Smucker
SJM
$12.7B
| $238K | 0.05% |
+2,290
| New | +$242K |
|
116
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.89B
| $227K | 0.05% |
+7,850
| New | +$217K |
|
117
Delta Air Lines
DAL
$60.5B
| $223K | 0.05% |
+3,809
| New | +$214K |
|
118
Nuveen ESG Mid-Cap Value ETF
NUMV
$455M
| $217K | 0.05% |
+7,175
| New | +$214K |
|
119
WD-40
WDFC
$3.1B
| $213K | 0.05% |
+1,098
| New | +$207K |
|
120
Bath & Body Works
BBWI
$4.06B
| $212K | 0.05% |
+14,483
| New | +$209K |
|
121
Vanguard International Dividend Appreciation ETF
VIGI
$9.19B
| $207K | 0.05% |
+2,869
| New | +$199K |
|
|
NVO
122
Novo Nordisk
NVO
$203B
| $205K | 0.05% |
+7,098
| New | +$197K |
|
|
RDS.A
123
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $203K | 0.05% |
+3,437
| New | +$201K |
|
124
Phillips 66
PSX
$82.4B
| $202K | 0.04% |
+1,840
| New | +$207K |
|
125
Nuveen Municipal Value Fund
NUV
$1.9B
| $123K | 0.03% |
+11,500
| New | +$121K |
|
Similar funds
PHP
PWPS
LOIM
MGCM
WAM
GHC
JWM
TC
Stokes Family Office's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Stokes Family Office, which disclosed 127 positions worth $450M. Its ten largest holdings account for 47% of the portfolio.
Its largest position is Vanguard Dividend Appreciation ETF: 520,044 shares worth $65M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, followed by Communication Services and Healthcare.
- Stokes Family Office's largest Q4 2019 buy was Vanguard Dividend Appreciation ETF: 520,044 shares worth $65M.
- Stokes Family Office's ten largest holdings make up 47% of its $450M portfolio in Q4 2019.
- Stokes Family Office disclosed 127 positions in Q4 2019, its first 13F filing on record.
Based on Stokes Family Office's 13F filing for Q4 2019, filed 10 Feb 2020.